Cholesterol Diet Withdrawal Leads to an Initial Plaque Instability and Subsequent Regression of Accelerated Iliac Artery Atherosclerosis in Rabbits

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Khanna, Vivek ^a   Jain, Manish ^a   Singh, Vishal ^a   Kanshana, Jitendra S ^a   Prakash, Prem ^a   Barthwal, Manoj K ^a   Murthy, Puvvada S R ^a   Dikshit, Madhu ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ARACHIS OIL; CD68 ANTIGEN; CHOLESTEROL; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 10; LIPID; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTERY INJURY; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROTIC PLAQUE; BALLOON; BLOOD VESSEL REACTIVITY; CHOLESTEROL DIET; CONTROLLED STUDY; GENE EXPRESSION; HISTOLOGY; ILIAC ARTERY; LIPID BLOOD LEVEL; LIPID STORAGE; MALE; NONHUMAN; RABBIT; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASOCONSTRICTION; VASODILATATION;

ACTINS; ANIMALS; ATHEROSCLEROSIS; CELL ADHESION MOLECULES; CHOLESTEROL, DIETARY; COLLAGEN; CYTOKINES; DIET, ATHEROGENIC; DISEASE PROGRESSION; FOAM CELLS; ILIAC ARTERY; INFLAMMATION MEDIATORS; LIPIDS; MALE; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH; PLAQUE, ATHEROSCLEROTIC; RABBITS;

EID: 84885713312     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077037     Document Type: Article

References (56)

1. Fuster V, Voute J, Hunn M, Smith SC Jr, (2007) Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern. Circulation 116: 1966-1970.
2. Singh V, Tiwari RL, Dikshit M, Barthwal MK, (2009) Models to study atherosclerosis: a mechanistic insight. Curr Vasc Pharmacol 7: 75-109.
3. Dornas WC, Oliveira TT, Augusto LE, Nagem TJ, (2010) Experimental atherosclerosis in rabbits. Arq Bras Cardiol 95: 272-278.
4. Phinikaridou A, Hallock KJ, Qiao Y, Hamilton JA, (2009) A robust rabbit model of human atherosclerosis and atherothrombosis. J Lipid Res 50: 787-797.
5. Nakazawa G, Finn AV, Ladich E, Ribichini F, Coleman L, et al. (2008) Drug-eluting stent safety: findings from preclinical studies. Expert Rev Cardiovasc Ther 6: 1379-1391.
6. Pasterkamp G, Schoneveld AH, Hillen B, Banga JD, Haudenschild CC, et al. (1998) Is plaque formation in the common carotid artery representative for plaque formation and luminal stenosis in other atherosclerotic peripheral arteries? A post mortem study. Atherosclerosis 137: 205-210.
7. Tzafriri AR, Vukmirovic N, Kolachalama VB, Astafieva I, Edelman ER, (2010) Lesion complexity determines arterial drug distribution after local drug delivery. J Control Release 142: 332-338.
8. VanderLaan PA, Reardon CA, Getz GS, (2004) Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol 24: 12-22.
9. Francis AA, Pierce GN, (2011) An integrated approach for the mechanisms responsible for atherosclerotic plaque regression. Exp Clin Cardiol 16: 77-86.
10. Malinow MR, (1980) Atherosclerosis. Regression in nonhuman primates. Circ Res 46: 311-320.
11. Malinow MR, (1983) Experimental models of atherosclerosis regression. Atherosclerosis 48: 105-118.
12. Okabe T, Hoshiga M, Negoro N, Nakakoji T, Arishiro K, et al. (2011) Rabbit plaque models closely resembling lesions in human coronary artery disease. Int J Cardiol 147: 271-277.
13. Riedmuller K, Metz S, Bonaterra GA, Kelber O, Weiser D, et al. (2010) Cholesterol diet and effect of long-term withdrawal on plaque development and composition in the thoracic aorta of New Zealand White rabbits. Atherosclerosis 210: 407-413.
14. Ferrer MD, Esteban E, Liste F, Carrillo JM, Ramos JJ, et al. (2010) [The rabbit as an experimental model: technique for the induction of vascular lesions and incidents]. Radiologia 52: 45-50.
15. Haarer SL, Emig LL, Keiser JA, (1998) Vascular remodeling in balloon injured rabbit iliac arteries. Basic Res Cardiol 93: 210-217.
16. Shinohara M, Kawashima S, Yamashita T, Takaya T, Toh R, et al. (2005) Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries. Cardiovasc Res 68: 249-258.
17. Meguro K, Iida H, Takano H, Morita T, Sata M, et al. (2009) Function and role of voltage-gated sodium channel NaV1.7 expressed in aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 296: H211-219.
18. Liu MW, Lin SJ, Chen YL, (1996) Local alcohol delivery may reduce phenotype conversion of smooth muscle cells and neointimal formation in rabbit iliac arteries after balloon injury. Atherosclerosis 127: 221-227.
19. Gomez-Garre D, Munoz-Pacheco P, Gonzalez-Rubio ML, Aragoncillo P, Granados R, et al. (2009) Ezetimibe reduces plaque inflammation in a rabbit model of atherosclerosis and inhibits monocyte migration in addition to its lipid-lowering effect. Br J Pharmacol 156: 1218-1227.
20. Son DJ, Lee HW, Shin HW, Lee JJ, Yoo HS, et al. (2008) Enhanced release of sphingosine-1-phosphate from hypercholesterolemic platelets: role in development of hypercholesterolemic atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 78: 383-390.
21. Hansson J, Vasan RS, Arnlov J, Ingelsson E, Lind L, et al. (2011) Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study. PLoS One 6: e16185.
22. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, et al. (1998) Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 97: 2433-2444.
23. Dapson RW, Fagan C, Kiernan JA, Wickersham TW, (2011) Certification procedures for sirius red F3B (CI 35780, Direct red 80). Biotech Histochem 86: 133-139.
24. Moreno PR, Purushothaman KR, Fuster V, O'Connor WN, (2002) Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation 105: 2504-2511.
25. Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R, (2002) Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation 105: 297-303.
26. Herrero-Beaumont G, Marcos ME, Sanchez-Pernaute O, Granados R, Ortega L, et al. (2008) Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol 154: 843-851.
27. Tian J, Hu S, Sun Y, Ban X, Yu H, et al. (2012) A novel model of atherosclerosis in rabbits using injury to arterial walls induced by ferric chloride as evaluated by optical coherence tomography as well as intravascular ultrasound and histology. J Biomed Biotechnol 2012: 121867.
28. Dong B, Zhang C, Feng JB, Zhao YX, Li SY, et al. (2008) Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 1270-1276.
29. Candipan RC, Hsiun PT, Pratt R, Cooke JP, (1994) Vascular injury augments adrenergic neurotransmission. Circulation 89: 777-784.
30. Krejcy K, Schwarzacher S, Ferber W, Plesch C, Cybulsky MI, et al. (1996) Expression of VCAM-1 in rabbit iliac arteries is associated with vasodilator dysfunction of regenerated endothelium following balloon injury. Atherosclerosis 122: 59-67.
31. Wang BY, Candipan RC, Arjomandi M, Hsiun PT, Tsao PS, et al. (1996) Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol 28: 1573-1579.
32. Khanna V, Jain M, Barthwal MK, Kalita D, Boruah JJ, et al. (2011) Vasomodulatory effect of novel peroxovanadate compounds on rat aorta: Role of rho kinase and nitric oxide/cGMP pathway. Pharmacol Res 64: 274-282.
33. Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-534, 536-537.
34. Li CJ, Sun HW, Zhu FL, Chen L, Rong YY, et al. (2007) Local adiponectin treatment reduces atherosclerotic plaque size in rabbits. J Endocrinol 193: 137-145.
35. Orlandi A, Marcellini M, Spagnoli LG, (2000) Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 20: 1123-1136.
36. Watanabe N, Ikeda U, (2004) Matrix metalloproteinases and atherosclerosis. Curr Atheroscler Rep 6: 112-120.
37. Newby AC, Zaltsman AB, (1999) Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res 41: 345-360.
38. Nadkarni SK, Bouma BE, de Boer J, Tearney GJ, (2009) Evaluation of collagen in atherosclerotic plaques: the use of two coherent laser-based imaging methods. Lasers Med Sci 24: 439-445.
39. CWM A (1967) Vascular Histochemistry In relation to the chemical and structural pathology of cardiovascular disease. Lloyd-luke (Medical books Ltd), London.
40. Friedman M, Byers SO, (1963) Observations Concerning the Evolution of Atherosclerosis in the Rabbit after Cessation of Cholesterol Feeding. Am J Pathol 43: 349-359.
41. Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, et al. (1996) Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7: 330-335.
42. Loftus IM, Naylor AR, Bell PR, Thompson MM, (2002) Matrix metalloproteinases and atherosclerotic plaque instability. Br J Surg 89: 680-694.
43. St Clair RW, (1983) Atherosclerosis regression in animal models: current concepts of cellular and biochemical mechanisms. Prog Cardiovasc Dis 26: 109-132.
44. Feig JE, Feig JL, (2012) Macrophages, dendritic cells, and regression of atherosclerosis. Front Physiol 3: 286.
45. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP, (2009) Collagens in the progression and complications of atherosclerosis. Vasc Med 14: 73-89.
46. Lee HM, Kim HJ, Won KJ, Choi WS, Park SH, et al. (2008) Soluble form of vascular cell adhesion molecule 1 induces migration and proliferation of vascular smooth muscle cells. J Vasc Res 45: 259-268.
47. Zaltsman AB, George SJ, Newby AC, (1999) Increased secretion of tissue inhibitors of metalloproteinases 1 and 2 from the aortas of cholesterol fed rabbits partially counterbalances increased metalloproteinase activity. Arterioscler Thromb Vasc Biol 19: 1700-1707.
48. Dollery CM, Humphries SE, McClelland A, Latchman DS, McEwan JR, (1999) Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. Circulation 99: 3199-3205.
49. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG, (1986) Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ Res 58: 783-789.
50. Minor RL Jr, Myers PR, Guerra R Jr, Bates JN, Harrison DG, (1990) Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 86: 2109-2116.
51. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, et al. (1992) Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 90: 1168-1172.
52. Hagensen MK, Raarup MK, Mortensen MB, Thim T, Nyengaard JR, et al. (2012) Circulating endothelial progenitor cells do not contribute to regeneration of endothelium after murine arterial injury. Cardiovasc Res 93: 223-231.
53. Moreno PR, Sanz J, Fuster V, (2009) Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol 53: 2315-2323.
54. Dowell FJ, Hamilton CA, Lindop GB, Reid JL, (1995) Development and progression of atherosclerosis in aorta from heterozygous and homozygous WHHL rabbits. Effects of simvastatin treatment. Arterioscler Thromb Vasc Biol 15: 1152-1160.
55. Wissler RW, Vesselinovitch D, (1988) Brief overview of the mounting evidence that atherosclerosis is both preventable and reversible. J Clin Apher 4: 52-58.
56. Al-Mallah MH, Nasir K, (2011) Plaque composition and stenosis severity: is there any hope for plaque regression? Atherosclerosis 219: 395-396.